565 related articles for article (PubMed ID: 28369768)
1. Drug repurposing from the perspective of pharmaceutical companies.
Cha Y; Erez T; Reynolds IJ; Kumar D; Ross J; Koytiger G; Kusko R; Zeskind B; Risso S; Kagan E; Papapetropoulos S; Grossman I; Laifenfeld D
Br J Pharmacol; 2018 Jan; 175(2):168-180. PubMed ID: 28369768
[TBL] [Abstract][Full Text] [Related]
2. Inventing new therapies without reinventing the wheel: the power of drug repurposing.
Papapetropoulos A; Szabo C
Br J Pharmacol; 2018 Jan; 175(2):165-167. PubMed ID: 29313889
[TBL] [Abstract][Full Text] [Related]
3. Repurposing of biologics and biopharmaceuticals.
Israr J; Alam S; Singh V; Kumar A
Prog Mol Biol Transl Sci; 2024; 205():277-302. PubMed ID: 38789184
[TBL] [Abstract][Full Text] [Related]
4. Drug repurposing screens and synergistic drug-combinations for infectious diseases.
Zheng W; Sun W; Simeonov A
Br J Pharmacol; 2018 Jan; 175(2):181-191. PubMed ID: 28685814
[TBL] [Abstract][Full Text] [Related]
5. Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.
Berger NA; Besson VC; Boulares AH; Bürkle A; Chiarugi A; Clark RS; Curtin NJ; Cuzzocrea S; Dawson TM; Dawson VL; Haskó G; Liaudet L; Moroni F; Pacher P; Radermacher P; Salzman AL; Snyder SH; Soriano FG; Strosznajder RP; Sümegi B; Swanson RA; Szabo C
Br J Pharmacol; 2018 Jan; 175(2):192-222. PubMed ID: 28213892
[TBL] [Abstract][Full Text] [Related]
6. Repurposing a novel parathyroid hormone analogue to treat hypoparathyroidism.
Krishnan V; Ma YL; Chen CZ; Thorne N; Bullock H; Tawa G; Javella-Cauley C; Chu S; Li W; Kohn W; Adrian MD; Benson C; Liu L; Sato M; Zheng W; Pilon AM; Yang NN; Bryant HU
Br J Pharmacol; 2018 Jan; 175(2):262-271. PubMed ID: 28898923
[TBL] [Abstract][Full Text] [Related]
7. Targeting phosphodiesterase 5 as a therapeutic option against myocardial ischaemia/reperfusion injury and for treating heart failure.
Korkmaz-Icöz S; Radovits T; Szabó G
Br J Pharmacol; 2018 Jan; 175(2):223-231. PubMed ID: 28213937
[TBL] [Abstract][Full Text] [Related]
8. Web-based Tools for Drug Repurposing: Successful Examples of Collaborative Research.
Vanhaelen Q
Curr Med Chem; 2021; 28(1):181-195. PubMed ID: 32003659
[TBL] [Abstract][Full Text] [Related]
9. Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New Treatments.
Juárez-López D; Schcolnik-Cabrera A
Arch Med Res; 2021 Apr; 52(3):243-251. PubMed ID: 33190955
[TBL] [Abstract][Full Text] [Related]
10. An Analytical Review of Computational Drug Repurposing.
Sadeghi SS; Keyvanpour MR
IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(2):472-488. PubMed ID: 31403439
[TBL] [Abstract][Full Text] [Related]
11. Drug databases and their contributions to drug repurposing.
Masoudi-Sobhanzadeh Y; Omidi Y; Amanlou M; Masoudi-Nejad A
Genomics; 2020 Mar; 112(2):1087-1095. PubMed ID: 31226485
[TBL] [Abstract][Full Text] [Related]
12. In silico drug repositioning: what we need to know.
Liu Z; Fang H; Reagan K; Xu X; Mendrick DL; Slikker W; Tong W
Drug Discov Today; 2013 Feb; 18(3-4):110-5. PubMed ID: 22935104
[TBL] [Abstract][Full Text] [Related]
13. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
14. Computational Drug Repurposing: Classification of the Research Opportunities and Challenges.
Sadeghi SS; Keyvanpour MR
Curr Comput Aided Drug Des; 2020; 16(4):354-364. PubMed ID: 31198115
[TBL] [Abstract][Full Text] [Related]
15. Drug repurposing: Iron in the fire for older drugs.
Sonaye HV; Sheikh RY; Doifode CA
Biomed Pharmacother; 2021 Sep; 141():111638. PubMed ID: 34153846
[TBL] [Abstract][Full Text] [Related]
16. Implementation of a Pipeline Using Disease-Disease Associations for Computational Drug Repurposing.
Balasundaram P; Kanagavelu R; James N; Maiti S; Veerappapillai S; Karuppaswamy R
Methods Mol Biol; 2019; 1903():129-148. PubMed ID: 30547440
[TBL] [Abstract][Full Text] [Related]
17. Drug repurposing: a systematic review on root causes, barriers and facilitators.
Krishnamurthy N; Grimshaw AA; Axson SA; Choe SH; Miller JE
BMC Health Serv Res; 2022 Jul; 22(1):970. PubMed ID: 35906687
[TBL] [Abstract][Full Text] [Related]
18. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.
Karatzas E; Kolios G; Spyrou GM
Methods Mol Biol; 2019; 1903():149-177. PubMed ID: 30547441
[TBL] [Abstract][Full Text] [Related]
19. Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidates.
Southan C; Williams AJ; Ekins S
Drug Discov Today; 2013 Jan; 18(1-2):58-70. PubMed ID: 23159359
[TBL] [Abstract][Full Text] [Related]
20. High Throughput and Computational Repurposing for Neglected Diseases.
Hernandez HW; Soeung M; Zorn KM; Ashoura N; Mottin M; Andrade CH; Caffrey CR; de Siqueira-Neto JL; Ekins S
Pharm Res; 2018 Dec; 36(2):27. PubMed ID: 30560386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
